Cyxtera Technologies, Inc.: Nasdaq/NYSE listing notice — Cyxtera receives Nasdaq notice for audit committee non-compliance after two director resignations

Cyxtera Technologies, Inc.

Nasdaq notified Cyxtera on March 30, 2023 that it no longer complies with audit committee independence rules due to resignations of Melissa Hathaway and Michelle Felman.
Company has 45 calendar days to submit a plan to regain compliance; if accepted, up to 180 days to cure.
No immediate effect on listing or trading of CYXT common stock on Nasdaq Global Market.
Board is seeking to appoint new independent directors who qualify for audit committee service.
If compliance plan is not accepted, Cyxtera may appeal before a Nasdaq Hearings Panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Cyxtera Technologies, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605

Exact text from the filing

March 30, 2023, Cyxtera Technologies, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the resignations of Melissa Hathaway and Michelle Felman from the Company’s board of directors and audit committee, effective on March 28, 2023, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rules 5605, which requires an audit committee of at least three independent directors. The Notice has no immediate effect on the listing or trading of the Company’s Class A common

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001794905-23-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.